• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by LAIX Inc.

    4/27/22 6:10:52 AM ET
    $LAIX
    Service to the Health Industry
    Miscellaneous
    Get the next $LAIX alert in real time by email
    6-K 1 d290625d6k.htm FORM 6-K Form 6-K

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

     

    FORM 6-K

     

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    For the month of April 2022

     

     

    Commission File Number: 001-38657

     

     

    LAIX Inc.

     

     

    Building C2, No. 1687 Changyang Road, Yangpu District

    Shanghai, 200090

    People’s Republic of China

    (Address of principal executive offices)

     

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

    Form 20-F  ☒            Form 40-F  ☐

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

     

     

     


    EXHIBIT INDEX

     

    Exhibit No.

      

    Description

    99.1    Press Release


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    LAIX Inc.
    By   :  

    /s/ Bing Sun

    Name:   :   Bing Sun
    Title:   :   Chief Financial Officer

    Date: April 27, 2022

    Get the next $LAIX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LAIX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LAIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by LAIX Inc. (Amendment)

      SC 13D/A - LAIX Inc. (0001742056) (Subject)

      7/8/22 1:51:02 PM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form SC 13D filed by LAIX Inc.

      SC 13D - LAIX Inc. (0001742056) (Subject)

      6/23/22 6:03:17 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form SC 13D/A filed by LAIX Inc. (Amendment)

      SC 13D/A - LAIX Inc. (0001742056) (Subject)

      6/21/22 6:17:08 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous

    $LAIX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Zhihu Inc. Announces Change of Independent Director

      BEIJING, May 27, 2025 (GLOBE NEWSWIRE) -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE:ZH, HKEX: 2390)), a leading online content community in China, today announced the appointment of Dr. Li-Lan Cheng as an independent director of the Company. Mr. Hanhui Sam Sun has resigned as an independent director of the Company, due to other professional endeavors. These changes are effective on May 27, 2025. For the committees under the board of directors, Dr. Li-Lan will serve as the chairman of the audit committee as well as a member of the compensation committee, nomination committee, and corporate governance committee. Dr. Li-Lan Cheng is currently an executive director and chief financial offic

      5/27/25 4:50:22 AM ET
      $YJ
      $ZH
      $JOBS
      $LAIX
      Other Specialty Stores
      Consumer Discretionary
      Business Services
      Diversified Commercial Services
    • LAIX Inc. Announces Plan to Implement ADS Ratio Change

      SHANGHAI, Feb. 21, 2022 /PRNewswire/ -- LAIX Inc. ("LAIX" or the "Company") (NYSE:LAIX), an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to its Class A ordinary shares (the "ADS Ratio"), par value US$0.001 per share, from the current ADS Ratio of one (1) ADS to one (1) Class A ordinary share to a new ADS Ratio of one (1) ADS to fourteen (14) Class A ordinary shares. A post-effective amendment to the ADS Registration Statement on Form F-6 will be filed with the SEC to reflect the change in the ADS Ratio. The Company antic

      2/21/22 7:00:00 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • LAIX Inc. Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price

      SHANGHAI, Sept. 28, 2021 /PRNewswire/ -- LAIX Inc. ("LAIX" or the "Company") (NYSE:LAIX), an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning, today announced that it has received a letter (the "Letter") from the New York Stock Exchange (the "NYSE") dated September 17, 2021 and further e-mail communication on the same date, notifying the Company that (i) it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs"), and (ii) the applicable cure period for the Company to regain compliance expires on March 17, 2022. Pursuant to applicable NYSE continued listing stan

      9/28/21 7:00:00 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous

    $LAIX
    Leadership Updates

    Live Leadership Updates

    See more
    • Zhihu Inc. Announces Change of Independent Director

      BEIJING, May 27, 2025 (GLOBE NEWSWIRE) -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE:ZH, HKEX: 2390)), a leading online content community in China, today announced the appointment of Dr. Li-Lan Cheng as an independent director of the Company. Mr. Hanhui Sam Sun has resigned as an independent director of the Company, due to other professional endeavors. These changes are effective on May 27, 2025. For the committees under the board of directors, Dr. Li-Lan will serve as the chairman of the audit committee as well as a member of the compensation committee, nomination committee, and corporate governance committee. Dr. Li-Lan Cheng is currently an executive director and chief financial offic

      5/27/25 4:50:22 AM ET
      $YJ
      $ZH
      $JOBS
      $LAIX
      Other Specialty Stores
      Consumer Discretionary
      Business Services
      Diversified Commercial Services

    $LAIX
    SEC Filings

    See more
    • SEC Form SC 13E3 filed by LAIX Inc.

      SC 13E3 - LAIX Inc. (0001742056) (Subject)

      7/11/22 8:52:23 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form 6-K filed by LAIX Inc.

      6-K - LAIX Inc. (0001742056) (Filer)

      6/27/22 4:02:01 PM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form 6-K filed by LAIX Inc.

      6-K - LAIX Inc. (0001742056) (Filer)

      6/17/22 9:10:37 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous